endpoint is the destination for people who are passionate about delivering the most innovative and high-quality IRT solutions for clinical trials. We find purpose through hard work and a commitment to excellence, resulting in a competitive advantage unparalleled in the industry.
Through endpoint’s culture of accountability and execution, we ensure that our customers are able to focus on the science of developing lifesaving medications for patients.
A world where seamlessly integrated technology drives clinical trials.
We collaborate and share knowledge to advance our mission.
We provide an environment in which you are encouraged and expected to do great things.
We are committed to hiring, developing and retaining the most dedicated and passionate people.
Everyone at endpoint is a leader.
endpoint’s IRT solutions drive new found efficiencies and unparalleled data transparency to support our customers’ search for novel therapies.
The endpoint mantra is ‘We Are the Patient’ — a persistent nod to the importance of everything that we do.
Our customers inform the endpoint road map — we listen to their challenges and provide novel solutions.
We deliver the most innovative patient and supply management solutions on the market through endpoint’s continuously evolving PULSE® platform.
Our belief is that endpoint should be the hub for e-Clinical technology integration.
When novel partnership opportunities arise, endpoint is the preferred partner to ensure the best outcome.
We ask you to trust us and we take that seriously. endpoint’s system of personnel, technology, policies, and processes embeds a quality, privacy, and security mindset in everything we do.
We make sound financial decisions to ensure long-term growth and prosperity for our shareholders.
They represent some of the sharpest minds in software development, project management, design management, testing, technical support, R&D, IT, data management, quality assurance.
VP Product Strategy
Cat started her career as an academic scientist in Molecular and Cellular before finishing her MBA and transitioning into Pharmaceutical Supply Chain Management. During her career, Cat developed notable expertise not only in clinical supplies but also in training development, process improvement, managing partnerships, and the design and implementation of technologies such as IRT. Catherine is most well known for bringing a focus to bridging the GMP/GCP gap by bringing supply chain customer service through the last mile to patients. Cat joined endpoint in 2019 as VP of Product Strategy to help continue to bring the customer voice forward into shaping the future of IRT. At home Cat is a wife and mother of 4 boys who inspire her every day to find what is good and do better.
Chief Technology Officer (CTO)
Nicholas (Nick) Mistry joined endpoint in 2019 as our Chief Technology Officer (CTO) following over two decades of technology leadership roles across diverse fields including space exploration, medical technology, speech recognition, and cloud computing. Most recently at Amazon, Nick lead Adaptive Pricing and the machine learning systems that evaluate prices, at scale, for every item that Amazon ships and sells. His core focus will be growing our world-class technology program through establishing a centralized Technology team to usher in new approaches with data-driven insight and industry-leading practices.
Christine Oliver is the CEO at endpoint, a proven leader in IRT and the clinical industry. Prior to joining endpoint in 2013, Christine worked in a variety of roles in the biotech/pharma industry including a five-year tenure with Takeda Oncology, where she created a team tasked with developing innovative ways to use IRT for clinical supplies logistics as well as forecasting and inventory management. Christine started her IRT career in 2000 as a member of the development team at PAREXEL/Perceptive, she later went on to lead its Product management group. Christine lives in Manchester by the Sea with her husband and four children.
VP Business Development
Ryan has been with endpoint since 2011. He started his career as an analyst for Salomon Smith Barney and moved into pharmaceutical services in 2005 as a biostatistician for a CRO before transitioning to business development in 2008. He has a BA in mathematics from the College of the Holy Cross and an MS in biostatistics from the University of Vermont.
Call us from within the United States:
Calling from outside the United States?